Cerebrospinal fluid: a target of some fungi and an overview

Memorias do Instituto Oswaldo Cruz

article

Corrêa-Moreira, Danielly¹  Castro, Rodolfo¹  da Costa, Gisela Lara¹  Lima-Neto, Reginaldo Gonçalves²  Oliveira, Manoel Marques Evangelista¹ 

[1] Fundação Oswaldo Cruz-Fiocruz;Universidade Federal de Pernambuco

关键词: fungal meningitis;    diagnosis;    cerebrospinal fluid;   

DOI  :  10.1590/0074-02760220251

学科分类：地质学

来源: Bioline International

【 摘 要 】

Meningitis is a potentially life-threatening infection characterised by the inflammation of the leptomeningeal membranes. The estimated annual prevalence of 8.7 million cases globally and the disease is caused by many different viral, bacterial, and fungal pathogens. Although several genera of fungi are capable of causing infections in the central nervous system (CNS), the most significant number of registered cases have, as causal agents, yeasts of the genus Cryptococcus. The relevance of cryptococcal meningitis has changed in the last decades, mainly due to the increase in the number of people living with human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) and medications that impair the immune responses. In this context, coronavirus disease 19 (COVID-19) has also emerged as a risk factor for invasive fungal infections (IFI), including fungal meningitis (FM), due to severe COVID-19 disease is associated with increased pro-inflammatory cytokines, interleukin (IL)-1, IL-6, and tumour necrosis factor-alpha, reduced CD4-interferon-gamma expression, CD4 and CD8 T cells. The gold standard technique for fungal identification is isolating fungi in the culture of the biological material, including cerebrospinal fluid (CSF). However, this methodology has as its main disadvantage the slow or null growth of some fungal species in culture, which makes it difficult to finalise the diagnosis. In conclusions, this article, in the first place, point that it is necessary to accurately identify the etiological agent in order to assist in the choice of the therapeutic regimen for the patients, including the implementation of actions that promote the reduction of the incidence, lethality, and fungal morbidity, which includes what is healthy in the CNS.

【 授权许可】

Free